These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13447208)

  • 1. Studies on the glycerides during the clearing reaction.
    CARLSON LA; WADSTROM LB
    Clin Chim Acta; 1957 Feb; 2(1):9-15. PubMed ID: 13447208
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of fat emulsion clearing activities of postheparin plasma and pancreatic lipase.
    HOLLETT C; MENG HC
    Am J Physiol; 1956 Feb; 184(2):428-32. PubMed ID: 13302438
    [No Abstract]   [Full Text] [Related]  

  • 3. [INFLUENCE OF ORAL LIPID ADMINISTRATION ON THE POST-HEPARIN "CLEARING" AND "LIPOLYTIC" POWER IN HEALTHY YOUNG PERSONS AND IN AGED ARTERIOSCLEROTIC PATIENTS].
    CONCONI F; MANENTI F; TORRI A; NAVA C
    Acta Vitaminol; 1964 Feb; 18():13-21. PubMed ID: 14157826
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative studies of triglyceride lipolysis after heparin administration.
    ENGELBERG H
    Circ Res; 1958 May; 6(3):266-70. PubMed ID: 13523805
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on plasma clearing factor. II. Substrates.
    Eiber HB; Payza AN; Goldberg B
    Biochim Biophys Acta; 1966 Apr; 116(2):256-63. PubMed ID: 5956912
    [No Abstract]   [Full Text] [Related]  

  • 6. Human plasma heparin levels and lipemia clearing activity after ingestion of animal and vegetable fat.
    ENGELBERG H
    J Appl Physiol; 1958 Sep; 13(2):296-8. PubMed ID: 13575347
    [No Abstract]   [Full Text] [Related]  

  • 7. The specificity of pancreatic lipase for the primary hydroxyl groups of glycerides.
    MATTSON FH; BECK LW
    J Biol Chem; 1956 Apr; 219(2):735-40. PubMed ID: 13319295
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of intravenous administration of fat emulsions and their emulsifying agents. I. Effects on clearing factor activity, electrophoretic pattern and clotting time of blood of dogs.
    LEVER WF; BASKYS B
    J Invest Dermatol; 1957 Apr; 28(4):317-20. PubMed ID: 13439224
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of glycerides in blood serum.
    CARLSON LA; WADSTROM LB
    Clin Chim Acta; 1959 Mar; 4(2):197-205. PubMed ID: 13639262
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECTS OF ACIDIC AZOPROTEINS ON PLASMA TRIGLYCERIDE LEVELS AND ON THE HEPARIN-ACTIVATED CLEARING SYSTEM.
    BROOME JD
    J Exp Med; 1964 Jan; 119(1):83-104. PubMed ID: 14113117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of pancreatic lipolysis of glycerides.
    BORGSTROM B
    Biochim Biophys Acta; 1954 Apr; 13(4):491-504. PubMed ID: 13159986
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of fat lipolysis by post-heparin human plasma lipoprotein lipase and by human pancreatic lipase.
    ENGELBERG H
    Circulation; 1959 Jun; 19(6):884-90. PubMed ID: 13663179
    [No Abstract]   [Full Text] [Related]  

  • 13. [Formation of partial glycerides during lipolysis of triglycerides in intestine].
    DESNUELLE P; CONSTANTIN MJ
    Biochim Biophys Acta; 1952 Nov; 9(5):531-7. PubMed ID: 13032151
    [No Abstract]   [Full Text] [Related]  

  • 14. MALDI imaging of enzymatic degradation of glycerides by lipase on textile surface.
    Hall-Andersen J; Kaasgaard SG; Janfelt C
    Chem Phys Lipids; 2018 Mar; 211():100-106. PubMed ID: 29122612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the specificity of assays for lipases in postheparin plasma.
    Nilsson-Ehle P
    Clin Chim Acta; 1984 Aug; 141(2-3):293-8. PubMed ID: 6488561
    [No Abstract]   [Full Text] [Related]  

  • 16. AN INVESTIGATION OF ROUTES OF ADMINISTRATION OF HEPARIN OTHER THAN INJECTION.
    WINDSOR E; FREEMAN L
    Am J Med; 1964 Sep; 37():408-16. PubMed ID: 14209287
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearing system for blood fats; stimulation by a heparinoid.
    DUNCAN CH; BEST MM; McGAFF CJ
    Lancet; 1959 May; 1(7081):1014-6. PubMed ID: 13655659
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin-activated clearing factor; standardized test, agewise application, and clinical observations.
    BAKER SP
    Circulation; 1957 Jun; 15(6):889-96. PubMed ID: 13437414
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticoagulant and clearing effects of heparin in hyperlipemia].
    PINTER I; CSERGO I; KARADY I
    Magy Tud; 1957; 8(1-2):65-8. PubMed ID: 13450579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.